Loss of Bombesin-Induced Feeding Suppression in Gastrin-Releasing Peptide Receptor-Deficient Mice

The gastrin-releasing peptide receptor (GRP-R) is one of three members of the mammalian bombesin subfamily of seven-transmembrane G protein-coupled receptors that mediate diverse biological responses including secretion, neuromodulation, chemotaxis, and growth. The X chromosome-linked GRP-R gene is...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 95; no. 6; pp. 3188 - 3192
Main Authors: Hampton, Lori L., Ladenheim, Ellen E., Akeson, Mark, Way, James M., Weber, H. Christian, Sutliff, Vince E., Jensen, Robert T., Wine, Lara J., Arnheiter, Heinz, Battey, James F.
Format: Journal Article
Language:English
Published: United States National Academy of Sciences of the United States of America 17-03-1998
National Acad Sciences
National Academy of Sciences
The National Academy of Sciences
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The gastrin-releasing peptide receptor (GRP-R) is one of three members of the mammalian bombesin subfamily of seven-transmembrane G protein-coupled receptors that mediate diverse biological responses including secretion, neuromodulation, chemotaxis, and growth. The X chromosome-linked GRP-R gene is expressed widely during embryonic development and predominantly in gastrointestinal, neuronal, and neuroendocrine systems in the adult. Surprisingly, gene-targeted mice lacking a functional GRP-R gene develop and reproduce normally and show no gross phenotypic abnormalities. However, peripheral administration of bombesin at dosages up to 32 nmol/kg to such mice had no effect on the suppression of glucose intake, whereas normal mice showed a dose-dependent suppression of glucose intake. These data suggest that selective agonists for the GRP-R may be useful in inducing satiety.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Communicated by Julius Axelrod, National Institute of Mental Health, Bethesda, MD
To whom reprint requests should be addressed. e-mail: jbattey@pop.nidcd.nih.gov.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.95.6.3188